Subsidiaries Silence EContact Us>

▲

170.00p (+1.00p)
Vol: 15000
(15-minute delayed)
View full stock quote

About Us
Platform Technologies
Pipeline
Collaborations
Investor Relations
News & Events
RNAi Hub

Menu
About Us
RNAI Platform
Pipeline
- Overview
- Pre-Clinical development
Collaborations
Investor Relations
News & Events
RNAi Hub
Contact

Silence Therapeutics’ partner Quark initiates next stage of clinical trials on DGF

Posted on January 8, 2009 by fwm_admin

Posted in News and Events by Silence

Comment

Name Please enter your name

Email Please enter a valid email address

Comment Please enter a comment
>

Submit

Please enter a search term

Sign up to receive alerts

Email

Please enter a valid email address >

Submit

ARCHIVES

2013

June 2013
May 2013
April 2013
March 2013
February 2013
January 2013

2012

December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012

2011

December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011

2010

December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010

2009

December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009

2008

December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008

2007

December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007

2006

November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006

2005

December 2005
November 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005

2004

October 2004
July 2004
June 2004

2003

December 2003
May 2003

TAGS

Arrowhead Research Corporation Biochem Biophys Res Commun Biochim Biophys Acta Biomaterials Blood BMC Genomics BMC Plant Biol cancer Cancer Res Cell Curr Biol Dev Biol Genes Dev Genetics Industry News Insect Biochem Mol Biol Int J Oncol J Biol Chem J Cell Sci J Virol Mariana Bio Methods Mol Biol microRNA Micro RNA Blog Mirapharm mirna Mol Biol Cell Mol Biol Rep Mol Cell Biol Mol Ther Mol Ther Nucleic Acids Nucleic Acids Res Oncol Rep Plant Biotechnol J Plant Physiol PLoS Genet PLoS One PLoS Pathog Proc Natl Acad Sci U S A Report Report Linker RNAi Santaris silence therapeutics Uncategorized

Quick Links

Home
About Us
Platform Technologies
Pipeline
Collaborations
Investor Relations
News & Events
RNAi HUB
Site Map

Contact

3 Shortlands
Hammersmith
London W6 8DA
United Kingdom

Tel:+44 (0) 333 9880 140
Fax:+44 (0) 795 731 8494

Copyright © 2013 Silence Therapeutics.
All rights reserved.

Terms of Use
Forward-Looking Statement